Over the course of his career, healthcare investor and entrepreneur Dr. Harry Stylli has provided executive leadership to numerous innovative companies. Dr. Harry Stylli currently serves as chairman of OncoCellMDx, a privately held diagnostic testing developer. Using technologies created internally and licensed through Harvard Medical School, the company has created non-invasive blood-based tests to evaluate a cancer’s grade and level of aggression..  Continue.

Latest News

What Is Cancer Genomics and How Can It Cure Cancer?

What Is Cancer Genomics and How Can It Cure Cancer?

Cancer genomics is regarded by experts worldwide as holding the key to finding a cure for cancer. In this article we examine what cancer genomics is and its potential to save millions of lives.   What is cancer genomics? The genome is our genetic blueprint containing all of our DNA. DNA is the genetic data… Continue Reading

6 of the Most Important Biotech Discoveries

6 of the Most Important Biotech Discoveries

The scientific field of biotechnology has made huge advancements in recent years, improving not only the health of individuals and society as a whole, but also the health of the planet. Here we take a look at some of biotechnology’s most important discoveries.     Biotechnology in food production Crop biotechnology is increasingly implemented by… Continue Reading

What Is Microbiome Sequencing and Why Should You Do It

What Is Microbiome Sequencing and Why Should You Do It

In recent years, our understanding of the microbiome and its importance to human health has grown significantly. Here we take a look at what the human microbiome is, what it does, and why experts are looking to the microbiome, not just in terms of nutritional health, but in the search for a cure for serious… Continue Reading

5 Important Facts You Need To Know about Cancer Genomics

5 Important Facts You Need To Know about Cancer Genomics

Cancer genomics is a relatively new area of scientific study that lies at the heart of personalized medicine, an ever-expanding field of medical care aimed not merely at treating the external symptoms, but also at tackling disease on a tailor-made, cellular level. Here, we take a look at cancer genomics, including how it began, how… Continue Reading